Figure 3.

Glomerular filtration rate (ml/min per 1.73 m²) estimated (eGFR) according to the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation at the time of INS diagnosis; at the time of apheresis; and at 1, 3, and 6 months, and at last follow-up, in patients with and without remission. Treatment efficacy (remission vs. no remission) was evaluated based on the results for serum albumin concentration and urinary protein concentration at last follow-up. Median follow-up was 12 [6.5–43] months. Data are expressed as medians and interquartile range. Patients on dialysis (5 patients in the no-remission group) were considered to have an eGFR of 0 ml/min per 1.73 m²). Remission versus no remission at each time point: P ≥ 0.05.